ALEXIS PAULSON: Open Payments
NPI 1790969046 · SANTA MARIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$225 in 10 payments from 5 companies in 2025. Trend: 2023 $14 · 2024 $0 · 2025 $225
Food & beverage: $225
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 3 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $68 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Coherus Oncology, Inc. | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: CABOMETYX, KEYTRUDA, LYNPARZA, ENHERTU, LOQTORZI, TAGRISSO, TECVAYLI.
Industry payments across CA — which companies pay providers there.
